Efficacy and safety of tralokinumab in adolescents with moderate-to-severe atopic dermatitis: results of the phase III ECZTRA 6 trial

BRITISH JOURNAL OF DERMATOLOGY(2022)

引用 14|浏览4
暂无评分
摘要
N/A
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要